Last reviewed: May 28, 2026
Last updated: May 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Yes, you can build muscle while on GLP-1 medications, but success depends on deliberate protein intake, progressive resistance training, and medical oversight. Research shows that 1.6–2.2 grams of protein per kilogram of body weight daily, combined with structured strength training, supports lean muscle maintenance or growth even during appetite suppression.
Many patients worry GLP-1 therapy automatically causes muscle loss due to reduced caloric intake. Understanding the clinical evidence and your individual biomarker profile can help you develop a targeted nutrition and exercise strategy that aligns with your body composition goals while benefiting from weight management treatment.
The Muscle-Loss Risk: What Clinical Studies Show
GLP-1 medications reduce appetite and slow gastric emptying, which can lower total calorie intake by 20–30%. Without intentional protein and resistance training, some patients experience a higher ratio of muscle loss to fat loss during weight reduction. Studies on semaglutide show that passive weight loss (diet alone) results in approximately 25–30% of weight lost coming from lean mass.
However, clinical trials combining GLP-1 therapy with resistance training and adequate protein demonstrate that lean mass can be preserved or even increased. A 2023 analysis found participants who maintained protein intake above 1.6 g/kg and performed strength training 3+ times weekly experienced fat loss while retaining or building muscle tissue.
Protein, Resistance Training, and Biomarker Context
Successful muscle building on GLP-1 therapy hinges on three factors: sufficient protein, progressive resistance exercise, and appetite management. Your individual genetic predispositions in peptide metabolic pathways—such as GLP1R and MC4R gene variants—may influence how your body responds to medications and handles protein digestion, providing context for personalized nutrition planning with your provider.
| Factor |
Clinical Recommendation |
| Protein Intake |
1.6–2.2 g/kg body weight daily; space across 4–5 meals to overcome appetite suppression |
| Resistance Training |
3–4 sessions weekly, progressive overload; 8–12 reps per set for hypertrophy |
| Calorie Deficit |
Moderate (300–500 kcal below baseline); aggressive deficits increase muscle loss risk |
| Biomarker Context |
Genetic variants in GLP1R, MC4R, GIPR influence appetite regulation and protein utilization patterns |
Overcoming Appetite Suppression to Meet Protein Goals
GLP-1-induced appetite reduction makes hitting daily protein targets challenging. Practical strategies include consuming protein-dense foods first during meals, using liquid protein (shakes, broth-based soups), eating smaller, frequent meals, and choosing foods with minimal volume relative to protein content—like lean meat, fish, Greek yogurt, and cottage cheese.
Some patients report that their appetite suppression plateaus after 8–12 weeks, allowing easier food intake. Others maintain significant appetite reduction long-term. Monitoring your hunger patterns and adjusting meal timing can help you find a sustainable rhythm that supports both GLP-1 efficacy and muscle-building nutrition goals.
Medical Monitoring and Who Should Prioritize Muscle Building on GLP-1
Before starting GLP-1 therapy with a muscle-building goal, discuss baseline body composition, existing strength training experience, and nutritional capacity with your provider. Individuals with metabolic syndrome, diabetes, or sedentary history may benefit from conservative GLP-1 dosing paired with early resistance training to establish baseline strength before significant weight loss occurs.
Patients should expect regular check-ins to assess appetite adequacy, protein intake, energy levels during workouts, and body composition changes. If you experience excessive fatigue, strength loss, or inability to meet protein targets, your provider may adjust medication timing, dose, or frequency to support your fitness objectives alongside weight management.
How PlexusDx Supports a More Personalized Approach
PlexusDx's Precision Peptide Genetic Test examines key variants in GLP1R, MC4R, GIPR, and FTO genes that may help provide context regarding how your body regulates appetite, metabolic rate, and lean mass distribution. These genetic predispositions do not predict exact medication response but can inform conversations with your provider about individualized protein and exercise strategies that align with your genetic metabolic profile.
Understanding your genetic biomarker landscape—such as whether you carry variants associated with higher or lower baseline GLP-1 receptor sensitivity—can support a more personalized conversation about realistic muscle-building timelines and nutritional support needs. The test should be interpreted with a qualified healthcare provider who can connect genetic insights to your clinical history and fitness goals.
When combined with a comprehensive assessment from a PlexusDx provider, genetic biomarker context helps you understand your body's unique response patterns to GLP-1 therapy, protein metabolism, and energy expenditure. This information can guide adjustments to protocol timing, dosing, or nutritional supplementation to better support lean mass goals.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Tirzepatide Maintenance Dose: Genetic & Biomarker Insights
Ozempic Dosing for Weight Loss: Clinical Guidance & Personaliz...